- Home
- IMMX vs GAME Comparison
IMMX vs GAME Comparison
Compare IMMX & GAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMX
- GAME
- Stock Information
- Founded
- IMMX 2014
- GAME 2011
- Country
- IMMX United States
- GAME United States
- Employees
- IMMX N/A
- GAME N/A
- Industry
- IMMX Medicinal Chemicals and Botanical Products
- GAME
- Sector
- IMMX Health Care
- GAME
- Exchange
- IMMX Nasdaq
- GAME Nasdaq
- Market Cap
- IMMX 82.6M
- GAME 66.6M
- IPO Year
- IMMX 2021
- GAME 2009
- Fundamental
- Price
- IMMX $3.05
- GAME $0.70
- Analyst Decision
- IMMX Strong Buy
- GAME Strong Buy
- Analyst Count
- IMMX 1
- GAME 2
- Target Price
- IMMX $8.00
- GAME $3.00
- AVG Volume (30 Days)
- IMMX 453.7K
- GAME 2.7M
- Earning Date
- IMMX 11-11-2025
- GAME 11-13-2025
- Dividend Yield
- IMMX N/A
- GAME N/A
- EPS Growth
- IMMX N/A
- GAME N/A
- EPS
- IMMX N/A
- GAME N/A
- Revenue
- IMMX N/A
- GAME $93,375,339.00
- Revenue This Year
- IMMX N/A
- GAME $2.32
- Revenue Next Year
- IMMX N/A
- GAME $26.42
- P/E Ratio
- IMMX N/A
- GAME N/A
- Revenue Growth
- IMMX N/A
- GAME 54.19
- 52 Week Low
- IMMX $1.34
- GAME $0.50
- 52 Week High
- IMMX $3.20
- GAME $2.87
- Technical
- Relative Strength Index (RSI)
- IMMX 77.89
- GAME 43.62
- Support Level
- IMMX $2.31
- GAME $0.66
- Resistance Level
- IMMX $2.82
- GAME $0.86
- Average True Range (ATR)
- IMMX 0.25
- GAME 0.05
- MACD
- IMMX 0.08
- GAME -0.00
- Stochastic Oscillator
- IMMX 95.41
- GAME 22.73
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged in revolutionizing the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. It's next generation media, entertainment, and technology helps creators and maximize their brand partners' return on investment. Its purpose-built platform provides marketing and creative services, offers data and analytics solutions, and amplifies awareness through FaZe Clan.